A detailed history of Van Eck Associates Corp transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Van Eck Associates Corp holds 1,384 shares of TXG stock, worth $22,254. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,384
Previous 2,122 34.78%
Holding current value
$22,254
Previous $41,000 48.78%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$15.71 - $23.49 $11,593 - $17,335
-738 Reduced 34.78%
1,384 $21,000
Q2 2024

Jul 31, 2024

SELL
$19.45 - $37.37 $2,158 - $4,148
-111 Reduced 4.97%
2,122 $41,000
Q1 2024

Apr 30, 2024

BUY
$36.08 - $54.3 $11,726 - $17,647
325 Added 17.03%
2,233 $83,000
Q4 2023

Feb 05, 2024

BUY
$34.32 - $57.55 $12,423 - $20,833
362 Added 23.42%
1,908 $107,000
Q3 2023

Nov 08, 2023

BUY
$40.86 - $62.98 $5,107 - $7,872
125 Added 8.8%
1,546 $64,000
Q2 2023

Aug 03, 2023

SELL
$50.96 - $58.72 $10,752 - $12,389
-211 Reduced 12.93%
1,421 $79,000
Q1 2023

May 03, 2023

BUY
$35.33 - $55.79 $3,780 - $5,969
107 Added 7.02%
1,632 $91,000
Q4 2022

Feb 08, 2023

BUY
$24.4 - $41.3 $4,880 - $8,260
200 Added 15.09%
1,525 $56,000
Q3 2022

Oct 27, 2022

SELL
$28.48 - $52.59 $2.47 Million - $4.57 Million
-86,854 Reduced 98.5%
1,325 $38,000
Q2 2022

Aug 03, 2022

BUY
$36.95 - $82.41 $337,131 - $751,908
9,124 Added 11.54%
88,179 $3.99 Million
Q1 2022

May 10, 2022

BUY
$55.7 - $145.79 $911,474 - $2.39 Million
16,364 Added 26.1%
79,055 $6.01 Million
Q4 2021

Jan 26, 2022

SELL
$135.05 - $182.59 $282,389 - $381,795
-2,091 Reduced 3.23%
62,691 $9.34 Million
Q3 2021

Nov 03, 2021

SELL
$145.58 - $192.14 $2.87 Million - $3.79 Million
-19,701 Reduced 23.32%
64,782 $9.43 Million
Q2 2021

Aug 10, 2021

SELL
$134.22 - $202.37 $912,427 - $1.38 Million
-6,798 Reduced 7.45%
84,483 $16.5 Million
Q1 2021

May 13, 2021

BUY
$140.25 - $196.86 $12.8 Million - $18 Million
91,281 New
91,281 $16.5 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.53B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Van Eck Associates Corp Portfolio

Follow Van Eck Associates Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.